- Home
- OPT vs HCSG Comparison
OPT vs HCSG Comparison
Compare OPT & HCSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPT
- HCSG
- Stock Information
- Founded
- OPT 1984
- HCSG 1976
- Country
- OPT Australia
- HCSG United States
- Employees
- OPT N/A
- HCSG N/A
- Industry
- OPT Biotechnology: Biological Products (No Diagnostic Substances)
- HCSG Assisted Living Services
- Sector
- OPT Health Care
- HCSG Health Care
- Exchange
- OPT Nasdaq
- HCSG Nasdaq
- Market Cap
- OPT 855.6M
- HCSG 838.4M
- IPO Year
- OPT 2020
- HCSG N/A
- Fundamental
- Price
- OPT $5.09
- HCSG $10.55
- Analyst Decision
- OPT Strong Buy
- HCSG Buy
- Analyst Count
- OPT 1
- HCSG 5
- Target Price
- OPT $12.00
- HCSG $13.80
- AVG Volume (30 Days)
- OPT 40.1K
- HCSG 522.6K
- Earning Date
- OPT 03-03-2025
- HCSG 02-12-2025
- Dividend Yield
- OPT N/A
- HCSG N/A
- EPS Growth
- OPT N/A
- HCSG 2.57
- EPS
- OPT N/A
- HCSG 0.53
- Revenue
- OPT $261,859.00
- HCSG $1,715,682,000.00
- Revenue This Year
- OPT N/A
- HCSG $5.26
- Revenue Next Year
- OPT $46,864.26
- HCSG $3.99
- P/E Ratio
- OPT N/A
- HCSG $19.91
- Revenue Growth
- OPT N/A
- HCSG 2.65
- 52 Week Low
- OPT $1.79
- HCSG $9.70
- 52 Week High
- OPT $6.30
- HCSG $13.00
- Technical
- Relative Strength Index (RSI)
- OPT 53.99
- HCSG 38.87
- Support Level
- OPT $4.77
- HCSG $10.40
- Resistance Level
- OPT $5.46
- HCSG $11.43
- Average True Range (ATR)
- OPT 0.32
- HCSG 0.42
- MACD
- OPT -0.11
- HCSG -0.01
- Stochastic Oscillator
- OPT 20.60
- HCSG 38.46
About OPT Opthea Limited
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
About HCSG Healthcare Services Group Inc.
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.